Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (5): 570-573.

Previous Articles     Next Articles

Clinical evaluation on marine capsules combined with the composite Salvia miltiorrhiza dropping pill in treatment of patients with cirrhosis related to chronic hepatitis B

WANG Chang-sheng, XU Hui-yang, KUAI Hui-fen   

  1. Department of InfectiousDiseases, Yijishan Hospital, Wannan Medical College, Wuhu 241001, Anhui, China
  • Received:2005-02-22 Revised:2005-03-17 Online:2005-05-26 Published:2020-11-19

Abstract: AIM: To investigate the therapeutic ef-fects of the marine capsules combined with composite Salvia miltiorrhiza dropping pill in treatment with patients with hepatic fibrosis related to chronic hepatitis B. METHODS: 54 patients were enrolled and randomly di-vided into control group and treatment group.The liver function, the marker of hepatic fibrosis and hepatitis B virus were determined before and after therapy. RESULTS: The markers in this study were significantly im-proved than those before treatment and those in control group (P<0.05 or P<0.01). CONCLUSION: The marine capsules combined with composite Salvia miltior-rhiza dropping pill can effectively control the activity of liver inflammation in the patients with chronic hepatitis B and markedly heighten the effects in treatment of patients with hepatic fibrosis and inhibit the replication of HBV without severe side effect.

Key words: chronic hepatitis B, marine capsules, composite Salvia miltiorrhiza dropping pill, hepatic fibro-sis

CLC Number: